Skip to main content

Table 2 Common insulin-like growth factor (IGF) haplotypesa and percentage mammographic density, Nurses' Health Study

From: Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study

Block 1 (p = 0.03)b

Block 2 (p = 0.95)b

Block 3 (p = 0.009)b

Block 4 (p = 0.007)b

Haplotype

Frequency (percentage)

βc (95% CI)

Haplotype

Frequency (percentage)

βc (95% CI)

Haplotype

Frequency (percentage)

βc (95% CI)

Haplotype

Frequency (percentage)

βc (95% CI)

1A (TG)

82.9

0.16

2A (GCC)

55.0

-0.002

3A (AGGCC)

46.5

0.08

4A (GGAA)

42.4

0.09

  

(-0.04 to 0.35)

  

(-0.15 to 0.14)

  

(-0.07 to 0.22)

  

(-0.06 to 0.23)

1B (TA)

13.3

-0.29

2B (GCG)

22.6

-0.04

3B (AGGCG)

13.6

0.03

4B (ACGA)

14.3

-0.03

  

(-0.52 to -0.07) d

  

(-0.21 to 0.14)

  

(-0.18 to 0.24)

  

(0.24 to 0.19)

Rare

3.9

--

2C (AAC)

12.7

0.03

3C (AGTCC)

11.0

0.15

4C (GGGA)

14.5

0.19

     

(-0.17 to 0.24)

  

(-0.09 to 0.38)

  

(-0.02 to 0.41)

   

2D (ACC)

9.0

0.03

3D (GGGGC)

9.1

-0.39

4D (ACGG)

8.8

-0.34

     

(-0.23 to 0.29)

  

(-0.65 to -0.14) e

  

(-0.61 to -0.06) h

   

Rare

0.8

--

3E (GGGCC)

8.2

0.35

4E (GGGG)

8.1

0.28

        

(0.07 to 0.62) f

  

(0.0007 to 0.55) i

      

3F (GAGGC)

7.6

-0.38

4F (AGAA)

7.6

-0.45

        

(-0.65 to -0.12) g

  

(-0.73 to -0.16) j

      

Rare

4.0

--

Rare

4.3

--

  1. CI, confidence interval. aIGF1 haplotype blocks are based on SNPs defined in Table 1. Block 1, SNPs 1 and 2; block 2, SNPs 3 to 5; block 3, SNPs 6 to 10; block 4, SNPs 11 to 14. bGlobal test of association based on F statistic comparing model with haplotypes in block and covariates with covariates only. cβ coefficients from models that used square-root-transformed mammographic density as the dependent variable. Multivariate-adjusted models including age (continuous), body mass index (continuous), alcohol consumption (category), age at first birth/parity, history of benign breast disease (yes/no), family history of breast cancer (yes/no), menopausal status/postmenopausal hormone use (premenopausal, postmenopausal never user, postmenopausal current user, postmenopausal past user). Results in bold show significant differences: d p = 0.009; e p = 0.003; f p = 0.02; g p = 0.005; h p = 0.02; i p = 0.05; j p = 0.002.